Simplex Trading’s Firefly Neuroscience AIFF Stock Holding History

Simplex Trading’s Portfolio AIFF Stock Details AIFF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-273	Closed	-$10K	–	11064
2022 Q2	$10K	Buy	+273	New	+$26.3K	﹤0.01%	8324

Other funds holding AIFF

Lafayette Investments Ashton, Maryland $494M AUM 11.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Simplex Trading's AIFF Position: Q2 2023 in Review

Simplex Trading sold out of Firefly Neuroscience (AIFF) in Q2 2023, closing a stake of 9 shares.

Simplex Trading first reported a position in AIFF in Q2 2022 and held it in 4 quarters. The position peaked at $16K in Q3 2022. 17 funds tracked by Wall St. Rank hold AIFF as of Q2 2023.

Simplex Trading reported no remaining Firefly Neuroscience position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 9 Firefly Neuroscience shares in Q2 2023.
Simplex Trading first reported a position in Firefly Neuroscience in Q2 2022 and held it in 4 quarters.
Simplex Trading's Firefly Neuroscience position peaked at $16K in Q3 2022.
17 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.